QR-koda

Screening and exploration of neoadjuvant “de-escalation” therapy for early breast cancer

BackgroundNeoadjuvant therapy for breast cancer improves the prognosis of high-risk patients. However, whether pathological completed response (pCR) can be used as a surrogate endpoint for de-escalation therapy in patients who are relatively sensitive to treatment remains to be elucidated.MethodsWe...

Olles dieđut

Furkejuvvon:
Váldodahkkit: Nana Zhang, Ming Shan, Zhenfeng Huang, Fei Gao, Bingqi Xu, Wenli Kang, Jian Zhang, Li Song, Jun Liu, Jiawei Zhang, Mingyang Liu, Haitao Jiang, Xinhang Liu, Zibo Shen, Peng Zhang, Abiyasi Nanding, Guoqiang Zhang
Materiálatiipa: Artigo
Giella:Inglês
Almmustuhtton: Frontiers Media S.A. 2025-03-01
Ráidu:Frontiers in Pharmacology
Fáttát:
breast cancer
neoadjuvant chemotherapy
pathological complete response
“de-escalation” therapy
prognosis
Liŋkkat:https://www.frontiersin.org/articles/10.3389/fphar.2025.1574665/full
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!

Geahča maid